Tag: humira-samsung

  • Samsung Bioepis seeks Europe approval for its Humira copy

    Biosimilars maker Samsung Bioepis, part of South Korea's top family-run conglomerate Samsung Group [SAGR.UL], said on Monday it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira. Samsung Bioepis said in a statement the European Medicines Agency has accepted for review its application to sell its biosimilar…

  • Samsung Bioepis seeks Europe approval for its Humira copy

    Biosimilars maker Samsung Bioepis, part of South Korea's top family-run conglomerate Samsung Group [SAGR.UL], said on Monday it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira. Samsung Bioepis said in a statement the European Medicines Agency has accepted for review its application to sell its biosimilar…

  • Day, Scott reject criticism of Rio boycott

    World number one Jason Day has hit back at critics of the golfers who have elected to skip the Rio de Janeiro Olympics. Golf's return to the Olympics for the first time since 1904 has been soured by the withdrawals of a number of top men's players, many of whom have cited health concerns due…